Sarcoma

John Wiley and Sons Ltd · United States · Est. 1972

ISSN1369-1643

SJR Q2✓ Scopus / SJR

Removed from DOAJ (2025-01-14). DOAJ's stated reason: Journal is inactive. A removal from the Directory of Open Access Journals is a quality/transparency signal — it can mean the journal became inactive or failed DOAJ's re-review criteria. This is not proof of predatory practice, but verify the journal's current status and policies before submitting. Check on DOAJ ↗

Journal Impact Factor

Not on record at PubScope. The Journal Impact Factor is published by Clarivate for Web of Science (JCR)–indexed journals. If this journal has one, it appears on the journal’s page ↗

📊 Standing in its field

Where this journal ranks among others in the same subject area.

SJR · Scopus

Top 50% in field

Clarivate’s JCR quartile is a separate ranking and may differ

SJR Scorei

0.56

H-Indexi

SNIPi

1.204

Total Worksi

873

Total Citationsi

21,077

2yr Mean Citednessi

3.11

Open Impact Factor alternative

Aims & Scope

Subject areas: Radiology, Nuclear Medicine and Imaging; Oncology.

General Information

Country / RegionUnited States

Primary Language—

1st Year Published1972

Annual Volume~ 10 articles / year

StatusActive (last: 2024)

Total Publications873

Publisher OrgHindawi Publishing Corporation

Visit Journal Website

Submission Info

Peer Review—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

5/11 · 45%

✅

Do you know the journal / publisher?

John Wiley and Sons Ltd

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1369-1643

✅

Indexed in a trusted database?

Scopus, PubMed

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

❌

Primary language documented?

N/A

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

624

2017

804

2018

648

2019

630

2020

276

2021

2022

2023

2024

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Radiology, Nuclear Medicine and ImagingQ2

OncologyQ3

Subject Classification

Scopus Categories

Radiology, Nuclear Medicine and ImagingOncology

Research Topics (OpenAlex)

Sarcoma Diagnosis and TreatmentBone Tumor Diagnosis and TreatmentsVascular Tumors and AngiosarcomasCardiac tumors and thrombiManagement of metastatic bone diseaseLymphoma Diagnosis and TreatmentSoft tissue tumor case studiesMusculoskeletal synovial abnormalities and treatmentsOral and Maxillofacial PathologySoft tissue tumors and treatment

Frequently asked questions about Sarcoma

Is Sarcoma a predatory journal?

Sarcoma was withdrawn from the Directory of Open Access Journals (DOAJ) — DOAJ's stated reason: "Journal is inactive" (2025-01-14). Withdrawal is not a predatory verdict, but it is a material editorial signal; it remains indexed in Scopus. Verify the journal's current status on DOAJ and its official site before submitting.

What is the impact factor of Sarcoma?

Sarcoma is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor. Its SCImago SJR score is 0.56.

Is Sarcoma indexed in Scopus and Web of Science?

Sarcoma is indexed in Scopus.

What is the aims and scope of Sarcoma?